RICHGEN Trademark

Trademark Overview


On Monday, June 25, 2018, a trademark application was filed for RICHGEN with the United States Patent and Trademark Office. The USPTO has given the RICHGEN trademark a serial number of 88014214. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2019. This trademark is owned by RichSource Stem Cells, Inc.. The RICHGEN trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
richgen

General Information


Serial Number88014214
Word MarkRICHGEN
Filing DateMonday, June 25, 2018
Status700 - REGISTERED
Status DateTuesday, September 10, 2019
Registration Number5854575
Registration DateTuesday, September 10, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements


Goods and ServicesHuman allograft tissue
Pseudo MarkRICH GEN

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 28, 2018
Primary Code005
First Use Anywhere DateThursday, June 21, 2018
First Use In Commerce DateThursday, June 21, 2018

Trademark Owner History


Party NameRichSource Stem Cells, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMount Pleasant, SC 29464

Party NameRichSource Stem Cells, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMount Pleasant, SC 29464

Party NameRichSource Stem Cells, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMount Pleasant, SC 29464

Trademark Events


Event DateEvent Description
Tuesday, October 16, 2018NON-FINAL ACTION E-MAILED
Thursday, July 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 15, 2018ASSIGNED TO EXAMINER
Tuesday, October 16, 2018NON-FINAL ACTION WRITTEN
Tuesday, October 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 2, 2019ASSIGNED TO LIE
Wednesday, November 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 28, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 30, 2018FINAL REFUSAL WRITTEN
Friday, November 30, 2018FINAL REFUSAL E-MAILED
Friday, November 30, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 24, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED

Related Keywords


richgen tissue allograft human